相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Prognostic markers and response to vandetanib therapy in sporadic medullary thyroid cancer patients
Vera Tiedje et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2016)
CARMA3 Represses Metastasis Suppressor NME2 to Promote Lung Cancer Stemness and Metastasis
Yi-Wen Chang et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
Hes1: a key role in stemness, metastasis and multidrug resistance
Zi-Hao Liu et al.
CANCER BIOLOGY & THERAPY (2015)
Wnt/β-Catenin activates MiR-183/96/182 expression in hepatocellular carcinoma that promotes cell invasion
Wilson K. C. Leung et al.
CANCER LETTERS (2015)
HES1 promotes metastasis and predicts poor survival in patients with colorectal cancer
Ruixue Yuan et al.
CLINICAL & EXPERIMENTAL METASTASIS (2015)
Negative regulation of RelA phosphorylation: Emerging players and their roles in cancer
Xinyuan Lu et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2015)
Response and toxicity of small-molecule tyrosine kinase inhibitors in patients with thyroid carcinoma: a systematic review and meta-analysis
E. N. Klein Hesselink et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2015)
miR-182 integrates apoptosis, growth, and differentiation programs in glioblastoma
Fotini M. Kouri et al.
GENES & DEVELOPMENT (2015)
The PDCD4/miR-21 pathway in medullary thyroid carcinoma
Gianmaria Pennelli et al.
HUMAN PATHOLOGY (2015)
Autocrine/Paracrine Human Growth Hormone-stimulated MicroRNA 96-182-183 Cluster Promotes Epithelial-Mesenchymal Transition and Invasion in Breast Cancer
Weijie Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
NOTCH pathway inactivation promotes bladder cancer progression
Antonio Maraver et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma
Samuel A. Wells et al.
THYROID (2015)
Dynamic expression and roles of Hes factors in neural development
Ryoichiro Kageyama et al.
CELL AND TISSUE RESEARCH (2015)
Noncoding RNA blockade of autophagy is therapeutic in medullary thyroid cancer
Justin S. Gundara et al.
CANCER MEDICINE (2015)
miR-182 targets CHL1 and controls tumor growth and invasion in papillary thyroid carcinoma ocr issue
Hongling Zhu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
RET Gene Mutations (Genotype and Phenotype) of Multiple Endocrine Neoplasia Type 2 and Familial Medullary Thyroid Carcinoma
Geoffrey W. Krampitz et al.
CANCER (2014)
Medical Management of Metastatic Medullary Thyroid Cancer
Jessica E. Maxwell et al.
CANCER (2014)
From Fly Wings to Targeted Cancer Therapies: A Centennial for Notch Signaling
Panagiotis Ntziachristos et al.
CANCER CELL (2014)
MicroRNA-182 modulates chemosensitivity of human non-small cell lung cancer to cisplatin by targeting PDCD4
Fang-ling Ning et al.
DIAGNOSTIC PATHOLOGY (2014)
MiR-129-5p is down-regulated and involved in the growth, apoptosis and migration of medullary thyroid carcinoma cells through targeting RET
Lijun Duan et al.
FEBS LETTERS (2014)
Medullary Thyroid Cancer in the Era of Tyrosine Kinase Inhibitors: To Treat or Not to Treat-and With Which Drug-Those Are the Questions
Maria E. Cabanillas et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
MicroRNA-182 drives metastasis of primary sarcomas by targeting multiple genes
Mohit Sachdeva et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Anti-miR182 Reduces Ovarian Cancer Burden, Invasion, and Metastasis: An In Vivo Study in Orthotopic Xenografts of Nude Mice
Xiaofei Xu et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Timing and extent of thyroid surgery for gene carriers of hereditary C cell disease-a consensus statement of the European Society of Endocrine Surgeons (ESES)
Bruno Niederle et al.
LANGENBECKS ARCHIVES OF SURGERY (2014)
Circulating miR-182 is a biomarker of colorectal adenocarcinoma progression
Lisa Perilli et al.
ONCOTARGET (2014)
Sp1-mediated microRNA-182 expression regulates lung cancer progression
Wen-Bin Yang et al.
ONCOTARGET (2014)
NF-κB, an Active Player in Human Cancers
Yifeng Xia et al.
CANCER IMMUNOLOGY RESEARCH (2014)
MiR-183/-96/-182 cluster is up-regulated in most breast cancers and increases cell proliferation and migration
Pei Li et al.
BREAST CANCER RESEARCH (2014)
RET revisited: expanding the oncogenic portfolio
Lois M. Mulligan
NATURE REVIEWS CANCER (2014)
Differential Gene Expression of Medullary Thyroid Carcinoma Reveals Specific Markers Associated with Genetic Conditions
Agnieszka Maliszewska et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
miRNA profiling of cancer
Gianpiero Di Leva et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2013)
A miRNA signature associated with human metastatic medullary thyroid carcinoma
Libero Santarpia et al.
ENDOCRINE-RELATED CANCER (2013)
Overexpression of miR-10a and miR-375 and downregulation of YAP1 in medullary thyroid carcinoma
Jena Hudson et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2013)
The upregulation of signal transducer and activator of transcription 5-dependent microRNA-182 and microRNA-96 promotes ovarian cancer cell proliferation by targeting forkhead box O3 upon leptin stimulation
Xiaofei Xu et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2013)
MicroRNA Expression Array Identifies Novel Diagnostic Markers for Conventional and Oncocytic Follicular Thyroid Carcinomas
Matthias Dettmer et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Pleiotropic effects of miR-183∼96∼182 converge to regulate cell survival, proliferation and migration in medulloblastoma
Shyamal Dilhan Weeraratne et al.
ACTA NEUROPATHOLOGICA (2012)
MicroRNA-182 downregulates metastasis suppressor 1 and contributes to metastasis of hepatocellular carcinoma
Jian Wang et al.
BMC CANCER (2012)
TGF-β induces miR-182 to sustain NF-κB activation in glioma subsets
Libing Song et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
The double-edged sword of Notch signaling in cancer
Andrew P. South et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2012)
MicroRNA Profiles in Familial and Sporadic Medullary Thyroid Carcinoma: Preliminary Relationships with RET Status and Outcome
Caterina Mian et al.
THYROID (2012)
MicroRNA Profiling of Sporadic and Hereditary Medullary Thyroid Cancer Identifies Predictors of Nodal Metastasis, Prognosis, and Potential Therapeutic Targets
Deepak Abraham et al.
CLINICAL CANCER RESEARCH (2011)
Germline RET sequence variation I852M and occult medullary thyroid cancer: harmless polymorphism or causative mutation?
Andreas Machens et al.
CLINICAL ENDOCRINOLOGY (2011)
Expression of the Active Notch1 Decreases MTC Tumor Growth In Vivo
Renata Jaskula-Sztul et al.
JOURNAL OF SURGICAL RESEARCH (2011)
Shielding the messenger (RNA): microRNA-based anticancer therapies
Elena Sotillo et al.
PHARMACOLOGY & THERAPEUTICS (2011)
MicroRNAs in NF-κB signaling
Xiaodong Ma et al.
JOURNAL OF MOLECULAR CELL BIOLOGY (2011)
The Notch/Hes1 Pathway Sustains NF-κB Activation through CYLD Repression in T Cell Leukemia
Lluis Espinosa et al.
CANCER CELL (2010)
Nuclear Factor-κB Contributes to Anaplastic Thyroid Carcinomas through Up-Regulation of miR-146a
Francesco Pacifico et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
E2F1 in Melanoma Progression and Metastasis
Vijay Alla et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Role of NF-κB in thyroid cancer
Francesco Pacifico et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2010)
The microRNA miR-182 is induced by IL-2 and promotes clonal expansion of activated helper T lymphocytes
Anna-Barbara Stittrich et al.
NATURE IMMUNOLOGY (2010)
Regulation of NOTCH signaling by reciprocal inhibition of HES1 and Deltex 1 and its role in osteosarcoma invasiveness
P. Zhang et al.
ONCOGENE (2010)
Transcriptome analysis in mouse tumors induced by Ret-MEN2/FMTC mutations reveals subtype-specific role in survival and interference with immune surveillance
D. Engelmann et al.
ENDOCRINE-RELATED CANCER (2009)
Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor
Miguel F. Segura et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Nuclear factor-κB activation is associated with somatic and germ line RET mutations in medullary thyroid carcinoma
Pitar Gallel et al.
HUMAN PATHOLOGY (2008)
MicroRNA expression profiling of thyroid tumors: Biological significance and diagnostic utility
Marina N. Nikiforova et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Expression of microRNA-146 suppresses NF-κB activity with reduction of metastatic potential in breast cancer cells
D. Bhaumik et al.
ONCOGENE (2008)
Suberoyl bis-hydroxamic acid activates notch-1 signaling and induces apoptosis in medullary thyroid carcinoma cells
Li Ning et al.
ONCOLOGIST (2008)
Off the beaten pathway: the complex cross talk between Notch and NF-kappa B
Clodia Osipo et al.
LABORATORY INVESTIGATION (2008)
Tumor suppressor role of Notch-1 signaling in neuroendocrine tumors
Muthusamy Kunnimalaiyaan et al.
ONCOLOGIST (2007)
Overexpression of the NOTCH1 intracellular domain inhibits cell proliferation and alters the neuroendocrine phenotype of medullary thyroid cancer cells
Muthusamy Kunnimalaiyaan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
BRAFV600E promotes invasiveness of thyroid cancer cells through nuclear factor κB activation
Iryna Palona et al.
ENDOCRINOLOGY (2006)
Evaluation of potential mechanisms underlying genotype-phenotype correlations in multiple endocrine neoplasia type 2
N. Mise et al.
ONCOGENE (2006)
Mechanisms of disease:: cancer targeting and the impact of oncogenic RET for medullary thyroid carcinoma therapy
Matthias Drosten et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2006)
Phosphorylation of NF-kappa B and I kappa B proteins: implications in cancer and inflammation
P Viatour et al.
TRENDS IN BIOCHEMICAL SCIENCES (2005)
Role of MEN2A-derived RET in maintenance and proliferation of medullary thyroid carcinoma
M Drosten et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Antitumor capacity of a dominant-negative RET Proto-oncogene mutant in a medullary thyroid carcinoma model
M Drosten et al.
HUMAN GENE THERAPY (2003)
HES and HERP families: Multiple effectors of the Notch signaling pathway
T Iso et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2003)